Singapore’s Temasek, through its ABC Impact fund, has snapped up a 16% stake in AC Health, the healthcare unit of Ayala Corporation. The deal involved subscribing to over 329 million shares, split between common and redeemable preferred shares.
The fresh capital will bankroll AC Health’s ambitious expansion—targeting 10 hospitals, 300 clinics, and 1,150 pharmacies by 2027. The group currently operates under core pillars: hospitals, multi-specialty clinics, and retail pharmacies.
The move reflects rising investor appetite for the Philippine healthcare sector, seen as resilient despite market volatility. AC Health emphasized that growth will come from a mix of organic initiatives and acquisitions, making it one of the country’s most aggressive healthcare consolidators.
Why it matters: As healthcare demand grows post-pandemic, Ayala’s push positions it to be a dominant player, while Temasek secures exposure to a sector with long-term upside.
